In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

“I’m proud of our team at Globus Medical, delivering incredible results ... disciplined approach to operational excellence ...

Forward-Looking Outlook With an impressive display of state-of-the-art solutions set to take center stage at AAOS, Globus Medical continues to underline its leadership in orthopedic advancements.

With a net margin of 4.03%, the company may face hurdles in effective cost management. Return on Equity (ROE): Globus Medical's ROE falls below industry averages, indicating challenges in ...

Debt Management: Globus Medical's debt-to-equity ratio is below the industry average. With a ratio of 0.13, the company relies less on debt financing, maintaining a healthier balance between debt ...